Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Bioanalytical Sample Batch Preparation – V 2.0

Posted on By

BA-BE Studies: SOP for Bioanalytical Sample Batch Preparation – V 2.0

Standard Operating Procedure for Bioanalytical Sample Batch Preparation in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/168/2025
Supersedes SOP/BA-BE/168/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To describe the procedure for organizing and preparing batches of plasma samples, calibrators, and quality controls for bioanalytical analysis in BA/BE studies using LC-MS/MS.

2. Scope

This SOP applies to all analysts involved in preparing analytical runs of clinical plasma samples, standards, and QC samples for BA/BE bioanalysis at the bioanalytical laboratory.

3. Responsibilities

  • Analyst: Prepares the sample batch layout, labels vials, and compiles
sequence information.
  • Supervisor: Reviews and approves the batch plan and randomization.
  • QA: Ensures integrity of randomization and compliance with SOP.
  • 4. Accountability

    The Head of Bioanalytical Operations is accountable for ensuring sample batch preparation aligns with study protocol, validated methods, and regulatory standards.

    5. Procedure

    5.1 Batch Layout and Planning

    1. Define batch size based on:
      • Instrument run time limits (e.g., <36 hrs)
      • Total number of subject samples
      • Number of replicates and QCs per batch
    2. Each batch must contain:
      • Blank samples (double and single)
      • At least 6 non-zero calibrators
      • Minimum 3 levels of QC (LQC, MQC, HQC) in duplicate
    3. Prepare Annexure-1: Batch Preparation Sheet listing injection order and vial positions.

    5.2 Randomization and Sample Arrangement

    1. Use software-generated randomization to assign sample IDs to vial positions.
    2. Include at least one anchor QC at beginning, middle, and end of the batch.
    3. Distribute study samples such that:
      • No sequential subject samples occur
      • Treatment arms are balanced across batches

    5.3 Vial Labeling and Loading

    1. Label all vials (calibrators, QCs, and samples) with printed barcode labels containing:
      • Sample ID
      • Vial position (e.g., A1, B5)
      • Run ID
    2. Arrange vials in autosampler trays as per layout sheet.
    3. Record physical arrangement in Annexure-2: Sample Tray Log.

    5.4 Sequence File Generation

    1. Create sequence file using instrument software:
      • Define injection order as per batch plan
      • Assign compound names, transitions, retention time, and integration parameters
    2. Save file with study code and batch number.
    3. Review sequence file and get QA sign-off before starting acquisition.

    5.5 Documentation

    1. All batch preparation documents must be signed and version-controlled.
    2. Attach randomization file, batch layout, tray map, and sequence file to analytical batch folder.
    3. Discrepancies must be recorded in Annexure-3: Batch Preparation Deviation Log.

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • LQC/MQC/HQC: Low/Mid/High Quality Control
    • QC: Quality Control
    • SOP: Standard Operating Procedure

    7. Documents

    1. Batch Preparation Sheet – Annexure-1
    2. Sample Tray Log – Annexure-2
    3. Batch Preparation Deviation Log – Annexure-3

    8. References

    • ICH M10 Guideline for Bioanalytical Method Validation
    • US FDA Bioanalytical Method Validation Guidance

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Batch Preparation Sheet

    Injection No. Sample Type Sample ID Vial Position
    1 Blank BLK A1
    2 Calibrator-1 STD01 A2
    15 Subject Sample BE101-TP3 C3

    Annexure-2: Sample Tray Log

    Tray ID Sample ID Position Checked By Date
    TR-05 BE101-TP3 C3 Rajesh Kumar 16/04/2025

    Annexure-3: Batch Preparation Deviation Log

    Date Deviation Observed Corrective Action Approved By
    16/04/2025 Wrong vial label for STD03 Relabeled and re-verified QA Manager

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial release New SOP QA Head
    17/04/2025 2.0 Inclusion of barcode labeling and deviation log Compliance update QA Head
    See also  BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: API Manufacturing: SOP for Maintenance of Reagent Labeling and Logs – V 2.0
    Next Post: Analytical Method Development: Preparation of Calibration Curve in UV – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version